Trends on the SGX Nifty hint at a favorable start for the index in India, with an 89-point rise. The support level is 17,500, while the resistance level is 17,700. The SGX Nifty is now at 17,698.80, up 87.75 points. The Nifty finished with gains for the second day in a row, with banks leading the gainers, with the index ending over 17,600. Bank Nifty rose more than 2% to new all-time highs, led by IndusInd and SBI, with ITC and Reliance also contributing.
Also Read| ITC share price jump nears to its 52 week high, sparks meme fest online
Top stocks in focus today:
Asian Granito India Ltd
Asian Granito India Ltd expects a 100 percent increase in exports in FY21-22, with a target of Rs350-400 crore in exports.
Also Read| Sensex rises over 150 points while Nifty above 17500 in early trades
Bank stocks
Bank stocks in spotlight | The Union Cabinet authorized a government guarantee of up to Rs 30,600 crore for security receipts issued by National Asset Reconstruction Company Ltd. (NARCL).
Also Read| NSE F&O Ban: Zee, IRCTC, LIC, Canara and others under ban today
IIFL Finance
The bulk transactions data indicated that IIFL Finance | CDC Group Plc sold 50 lakh equity shares in the firm for Rs 295.47 per share on the NSE and 1 crore shares at Rs 294.52 per share on the NSE.
Also Read| Apple stock slips after iPhone 13 launch event
Indiabulls Housing Finance
Indiabulls Housing Finance has authorized the offering of foreign currency convertible bonds (FCCB) at a floor price of Rs231.48 per FCCB, with the issue scheduled to begin on September 16.
Also Read| Nifty media surges over 11% led by Zee and Dish TV
Hero MotoCorp
Hero MotoCorp will increase the ex-showroom pricing of its bikes and scooters from September 20, 2021, to counteract the impact of constantly rising commodity prices.
Also Read| Sansera Engineering IPO opens today: All you need to know about the issue
Infosys
Frost Bank chose Infosys as a key partner for the introduction of a new home loan product offering.
Gyscoal Alloys
On September 15, Sampati Securities sold 18.9 lakh equity shares in the business in an open market transaction, lowering its ownership to 10.679 percent from 11.873 percent before.
Also Read| RIL share price falls over 2% as company delays Jiophone Next launch
CDSCO Cosara Diagnostics
To produce and commercialize the SARAGENE dengue test kit, CDSCO Cosara Diagnostics (a joint venture firm of Synbiotics, a fully-owned subsidiary of Ambalal Sarabhai Enterprises) got regulatory clearance from the (Central Drugs Standard Control Organization).